Literature DB >> 6322256

Neutrophil degranulation responses to combinations of arachidonate metabolites and platelet-activating factor.

J T O'Flaherty, R L Wykle, M J Thomas, C E McCall.   

Abstract

Polymorphonuclear neutrophils, when stimulated, rapidly form platelet-activating factor (PAF) and metabolize their arachidonate into 5-hydroperoxyeicosatetraenoate (5-HPETE), 5-hydroxyeicosatetraenoate (5-HETE), leukotriene (LT)A4, and LTB4. PAF and LTB4 degranulate neutrophils; 5-HETE, while lacking intrinsic degranulating actions, potentiates these responses. We now find that: a) 5-HPETE similarly potentiates the two lipids and has weak degranulating actions, b) LTA4 and LTB4 degranulate neutrophils by a common pathway, c) PAF degranulates neutrophils by a distinctly different pathway, d) the actions of either LT are additive to those of PAF, e) 5-HETE is particularly effective in potentiating response to combinations of PAF and LTB4, and f) combinations of the lipids partially circumvent requirements for cytochalasin B in these degranulation responses. Thus, the five lipids can be classified into potentiators (i.e., 5-HPETE and 5-HETE) and two types of independently acting agonists (i.e., LT's are one type, PAF a second type). At low concentrations, potentiator, LT, and PAF can all interact to produce prominent responses. They may similarly interact to promote function within their cells of origin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6322256

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  9 in total

1.  Differential control of azurophilic and specific granule exocytosis in Sendai-virus-permeabilized rabbit neutrophils.

Authors:  M M Barrowman; S Cockcroft; B D Gomperts
Journal:  J Physiol       Date:  1987-02       Impact factor: 5.182

Review 2.  Bioactions of 5-hydroxyicosatetraenoate and its interaction with platelet-activating factor.

Authors:  A G Rossi; J T O'Flaherty
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

3.  Differential effects of lipoxygenase products on FMLP and LTB4 evoked neutrophil aggregation.

Authors:  J K Beckman; J C Gay; A R Brash; J N Lukens; J A Oates
Journal:  Lipids       Date:  1985-06       Impact factor: 1.880

4.  Conversion of leukotriene A4 by neutrophils and platelets from patients with atopic dermatitis.

Authors:  R A Hilger; K Neuber; W König
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

5.  Stimulation by lipoxygenase products of superoxide anion production in FMLP-treated neutrophils.

Authors:  J K Beckman; J C Gay; A R Brash; J N Lukens; J A Oates
Journal:  Lipids       Date:  1985-05       Impact factor: 1.880

6.  Oxygen radical production by neutrophils from patients with bacterial infection and rheumatoid arthritis. Measurement of hydrogen peroxide may most accurately represent enhancement of oxygen radical production during infection.

Authors:  Y Ozaki; T Ohashi; Y Niwa
Journal:  Inflammation       Date:  1986-06       Impact factor: 4.092

7.  The role of 5-hydroperoxyeicosatetraenoic acid in neutrophil activation.

Authors:  A Seya; T Terano; Y Tamura; S Yoshida
Journal:  Agents Actions       Date:  1992-09

8.  Catalytic mechanism of thiol peroxidase from Escherichia coli. Sulfenic acid formation and overoxidation of essential CYS61.

Authors:  Laura M S Baker; Leslie B Poole
Journal:  J Biol Chem       Date:  2003-01-03       Impact factor: 5.157

9.  Electrospray mass spectrometric analysis of 5-hydroperoxy and 5-hydroxyeicosatetraenoic acids generated by lipid peroxidation of red blood cell ghost phospholipids.

Authors:  L M Hall; R C Murphy
Journal:  J Am Soc Mass Spectrom       Date:  1998-05       Impact factor: 3.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.